Cell Dissociation Market Size to Grow to USD 1.4 billion by 2028 at a CAGR of 17.8%

The cell dissociation market is projected to grow from USD 0.6 billion in 2023 to USD 1.4 billion by 2028 at a CAGR of 17.8%. The key factors driving the growth of the cell dissociation market are the increase in recombinant therapeutics sourced from mammalian cells, the growing focus on personalized medicine, and increasing GMP certification approvals for cell therapy production facilities. Additionally, advancements in non-enzymatic tissue dissociation are expected to offer lucrative market opportunities.

Get a Free Sample Copy of the Global Cell Dissociation Market Research Report at https://www.reportsnreports.com/contacts/requestsample.aspx?name=1424888

The cell dissociation market refers to the market for reagents and enzymes used in the dissociation of cells for various applications, such as cell culture, cell-based assays, and cell analysis. Cell dissociation reagents and enzymes are used to separate cells from tissues or from each other, while maintaining their viability and functionality.

The market for cell dissociation is driven by a growing demand for cell-based therapies, regenerative medicine, and biopharmaceuticals, as well as increasing funding for cell-based research. The market is also influenced by technological advancements in the field of cell biology, which have led to the development of more efficient and effective cell dissociation reagents and enzymes.

The market for cell dissociation is segmented based on product type, application, end-user, and region. By product type, the market is segmented into enzymes, reagents, and instruments. By application, the market is segmented into tissue dissociation, cell culture, flow cytometry, and others. By end-user, the market is segmented into biotechnology and pharmaceutical companies, research laboratories and institutes, and academic and government organizations. Geographically, the market is segmented into North America, Europe, Asia-Pacific, and Rest of the World.

List of Companies Profiled in the Report

Merck KGaA (Germany)
Danaher Corporation (US)
Thermo Fisher Scientific, Inc. (US)
Corning Incorporated (US)
Becton, Dickinson and Company (US)
STEMCELL Technologies (Canada)
PromoCell GmbH (Germany)
MiltenyiBiotec (Germany)
ATCC (US)
HiMedia Laboratories (India)
PAN-Biotech (Germany)
CellSystems GmbH (Germany)
AMSBIO (England)
Neuromics (US)
VitaCyte, LLC. (US)
ALSTEM (US)
Biological Industries (Israel)
Gemini Bio (US)
Innovative Cell Technologies, Inc. (US)
Central Drug House (P) Ltd. (India)
Worthington Biochemical Corporation (US)
Capricorn Scientific (Germany)
Abeomics (US)
Genlantis, Inc. (US)

Direct Purchase of the Global Cell Dissociation Market Research Report at https://www.reportsnreports.com/purchase.aspx?name=1424888

Overall, the cell dissociation market is expected to grow as the demand for cell-based research and therapies continues to increase. Technological advancements in the field of cell biology are also expected to drive the market growth, as new and more efficient cell dissociation reagents and enzymes are developed.

+ 1 347 333 3771
sales@reportsandreports.com

ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

This release was published on openPR.